ArticleCancers2021

Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin.

Hyehyun Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.